Nadda Visits NIPER Mohali, Reviews Biopharma Research and Innovation (See 'Corp Brief') BIS publishes six New Standards for Priority Assistive Products (See 'Corp Brief') Atmanirbhar Panchayat Program to focus on strengthening financial self-reliance of Panchayats (See 'Corp Brief') Bharat Khera Assumes Charge as Secretary, Ministry of MSME (See 'Corp Brief') Pilibhit in UP to get India's first integrated Basmati, organic training-cum-demo farm (See 'Corp Brief') FTA integrates Ayurveda and yoga into modern trade frameworks (See 'Corp Brief') India Grounds $6.1 Billion Investments in FY26, Expects 31,000 Jobs (See 'Corp Brief') Companies Act - Continuation of Look Out Circular invalid where no FIR is registered against person, all prior travel permissions are complied with & no material exists to show likelihood of him absconding: HC (See 'Legal Desk') Op Sindoor demonstrates transition from diplomatic statements to concrete action on terror (See 'Corp Brief') NARCL contributes to improving recovery outcomes & unlocking value for lenders (See 'Corp Brief') IPR - Issues relating to validity of trademark registrations, alleged misrepresentation, and authenticity of documents would be examined at trial, if no party is able to establish substantial goodwill in their respective marks: HC (See 'Legal Desk') DRDO & Indian Navy conduct maiden successful Salvo launch of NASM-SR missiles (See 'Corp Brief') Sacred relics of Lord Buddha arrive in Leh, witnesses spiritual gathering (See 'Corp Brief') PMLA - Separate properties of another company or LLP cannot be attached merely because of shareholding linkage, absent demonstrated money trail to such properties: SAFEMA (See 'Legal Desk') Electrification of buses & trucks is essential for achieving India's decarbonisation targets (See 'Corp Brief') Health-Seeking Behaviour Strengthens as Proportion of Population Reported Ailing in 2025 Nearly Doubles (See 'Corp Brief') IBC - Minimum default threshold u/s 4 is met in case involving operational debt denominated in foreign currency, if foreign currency amount is converted into Indian Rupees with reference to exchange rate prevailing on date of invoice: NCLT (See 'Legal Desk') Railway Minister to Flag Off Extended Srinagar-Jammu Vande Bharat (See 'Corp Brief') Competition Act - Tender conditions & eligibility criteria are primarily within procurer's domain and, absent evidence that such clauses restricts competition or cause exclusionary harm, no intervention is warranted: CCI (See 'Legal Desk') Secretary, DFS Lauds MUDRA Schemes of Financial Inclusion with Public Sector Banks (See 'Corp Brief') Trade Mark - Defendants' conduct of running a coordinated fraudulent recruitment scheme, impersonating the plaintiffs & extracting money from each candidate, is deliberate exploitation of plaintiffs' goodwill & causes reputational harm: HC (See 'Legal Desk') CCI approves Mizuho Securities to acquire certain equity of Avendus Capital (See 'Corp Brief') SAFEMA - Certain transaction falls within ambit of benami transaction where appellants failed to produce supporting material, despite opportunity, to establish legitimate source of funds either in hands of lender or alleged contributors: SAFEMA TRIBUNAL (See 'Legal Desk') CCI approves merger of A1 Agri Global, B.N. Agritech & Salasar Balaji Overseas (See 'Corp Brief') IBC - If corporate debtor is solvent & functioning company, then insolvency process invoked only to secure payment of individual dues by initiation of CIRP, amounts to misuse of IBC as recovery mechanism: SC (See 'Legal Desk') CCI approves acquisition by MAIF in Maple IM, Maple PM & Maple Trust (See 'Corp Brief') PMLA - Attachment of a residential property upheld where Act itself permits attachment not only of property directly acquired from proceeds of crime, but also of untainted property representing equivalent value where actual proceeds of crime are unavailable or untraceable: HC (See 'Legal Desk') World IP day - Govt announces 3-year fee waiver for sports-related IP registrations (See 'Corp Brief') IBC - If statutory authority, during subsistence of moratorium u/s 14, directs bank to place lien on bank accounts of Corporate Debtor, and bank acts on same, it would amount to execution against Corporate Debtor and is barred by Sec 14: NCLT (See 'Legal Desk') Reining in Misuse of IBC for Recovery (See CORP EINSICHT)

Print

Nadda Visits NIPER Mohali, Reviews Biopharma Research and Innovation

Published: May 02, 2026

By TIOLCorplaws News Service

NEW DELHI, MAY 02, 2026: UNION Minister for Chemicals & Fertilizers and Health & Family Welfare Jagat Prakash Nadda, visited the National Institute of Pharmaceutical Education and Research (NIPER), Mohali yesterday. During the visit, Minister inaugurated the NIPER Medicinal Succulents Garden.

Nadda reviewed the institute's strategic vision, research priorities, and innovation ecosystem. A comprehensive presentation by Prof. Dulal Panda Director, NIPER Mohali highlighted key performance indicators and the roadmap for strengthening research and industry linkages. The institute showcased its Centres of Excellence, including advanced work in biopharmaceuticals and emerging therapeutic domains, along with ongoing initiatives in technology transfer and commercialization.

Addressing the gathering, Nadda emphasized the Government of India's commitment to positioning the country at the forefront of biopharmaceutical advancements, particularly in APIs, key starting materials, synthesis intermediates, and biologics. He underscored the importance of strengthening research infrastructure and assured continued policy support and funding to accelerate innovation and execution in the sector. He also appreciated the institute's role in nurturing skilled, industry-ready professionals contributing to national growth.

Manoj Joshi, Secretary, Department of Pharmaceuticals interacted with faculty and students, inviting suggestions on enhancing industry collaboration, technology transfer, and translational research outcomes. He emphasized the need for reforms in the reward system to drive performance, suggesting incentives for faculty securing external funding and increasing industry-sponsored research. He also stressed the importance of transitioning from "paper patents" to real-world translation and commercialization to enhance national impact.

Highlighting the institute's contributions, Prof. Dulal Panda reaffirmed its focus on research excellence and its growing network of distinguished alumni. He outlined the institute's active role in advancing the Government's Biopharma SHAKTI mission through cutting-edge work in cell and gene therapies, biosimilars, medical devices, AI-driven pharmacoinformatics, and advanced drug delivery systems. The introduction of new Master's programmes in Biopharmaceuticals and Regulatory Affairs was also noted as a step towards building future-ready talent.

The visit was followed by a Technology Showcase in the Convention Centre foyer, where the Union Minister reviewed posters and prototypes demonstrating translational research outcomes. The showcase featured industry collaborations, patents, and clinical trial initiatives undertaken by NIPER.

The visit underscores the Government of India's sustained focus on strengthening pharmaceutical education, promoting innovation, and advancing research and development to build a robust and self-reliant biopharmaceutical ecosystem.

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
tioltube
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.